Fibroblast and Epidermal Growth Factors Utilize Different Signaling Pathways to Induce Anchorage-independent Cell Transformation in JB6 Cl41 Mouse Skin Epidermal Cells|RISS 상세보기

다국어 초록 (Multilingual Abstract)

Background: Extracellular stimulation of cells with growth factors such as epidermal growth factor (EGF) induces cell proliferation and cell transformation. Although fibroblast growth factor (FGF) is a well-known family member of growth factors and acts as a ligand of FGF receptor (FGFR), a receptor tyrosine kinase, in cytoplasmic membrane, the tumor promoter potential of FGF has not been clearly understood.
Methods: The role of FGF as a tumor promoter was determined measuring its effects of cell proliferation and transformation by the 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium and anchorage-independent cell transformation assays, respectively. The antibody specificity of phospho-RSK2 Tyr529 was determined by Western blotting using a purified FGFR kinase domain in vitro and the membrane fraction of JB6 Cl41 cells ex vivo. The signaling pathways mediated by FGF or EGF were determined by the comparisons of phosphorylation inhibitory efficacy using signaling inhibitors including kaempferol.
Results: FGF acted as a tumor promoter. FGF induced cell proliferation by stimulation of G1/S cell cycle transition, and anchorageindependent cell transformation in JB6 Cl41 cells. FGF-induced FGFR phosphorylation was suppressed by kaempferol treatment in a dose dependent manner. Interestingly, FGF stimulation utilized a non-canonical signaling pathway to activate RSK2 and activating transcription factor (ATF)-1, which was not transduced by EGF stimulation. Importantly, kaempferol inhibited tyrosine phosphorylation of FGFR by FGF stimulation and nuclear accumulation of phospho-ATF-1 at Ser63. Moreover, although kaempferol, 4'-N-benzoyl staurosporine(PKC412), 2-(2'-amino-3'-methoxyphenyl)oxanaphthalen-4-one (PD98059) and 1,4-diamino-2,3-dicyano-1,4-bis(2-aminophenylthio)butadiene (U0126) inhibited EGF-induced anchorage-independent cell transformation in JB6 Cl41 cells, FGF-induced cell transformation in soft agar was only inhibited by PKC412 and kaempferol, but not by PD98059 and U0126.
Conclusions: FGF acts as a tumor promoter and dual inhibition of kaempferol on the kinase activities of FGFR3 and RSK2 suppresses the FGF-induced neoplastic cell transformation through a non-canonical signaling pathway which is not utilized by EGF stimulation.

번역하기

참고문헌 (Reference)

1 Middleton E Jr, "The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer" 52 : 673-751, 2000

2 Beenken A, "The FGF family: biology, pathophysiology and therapy" 8 : 235-253, 2009

3 Johnson DE, "Structural and functional diversity in the FGF receptor multigene family" 60 : 1-41, 1993

4 Cho YY, "Ribosomal S6 kinase 2 is a key regulator in tumor promoter induced cell transformation" 67 : 8104-8112, 2007

5 Cho YY, "RSK2 as a key regulator in human skin cancer" 33 : 2529-2537, 2012

6 Cao Y, "R regulation of tumor angiogenesis and metastasis by FGF and PDGF signaling pathways" 86 : 785-789, 2008

7 Ellerbroek SM, "Phosphatidylinositol 3-kinase activity in epidermal growth factor-stimulated matrix metalloproteinase-9 production and cell surface association" 61 : 1855-1861, 2001

8 Jimeno A, "Pharmacogenomics of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors" 1766 : 217-229, 2006

9 Mosesson Y, "Oncogenic growth factor receptors: implications for signal transduction therapy" 14 : 262-270, 2004

10 Lee HS, "Mechanisms underlying apoptosis-inducing effects of Kaempferol in HT-29human colon cancer cells" 15 : 2722-2737, 2014